Craig C. Hopkinson, EVP R&D, Chief Medical Officer at Alkermes plc., sold ALKS on Aug 3, 2026
Data as of Oct 16
▼ SELL$437K9,000 shares at $48.58Craig C. Hopkinson EVP R&D, Chief Medical OfficerALKS Alkermes plc.
- Traded
- Aug 3, 2026
- Disclosed
- Aug 3, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ALKS since disclosure
−16.8%
after the sale
Similar stocks (XLV) since disclosure
+8.9%
XLV — its sector index fund
Change in closing price from Aug 3, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.